Soft Gel Matrices for Mesenchymal Stem Cell Growth Modulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The clinical applications of adult mesenchymal stem cells are limited due to rapid aging ex vivo, which restricts their expansion and engineering, and immortalizing these cells through telomerase transduction can lead to uncontrolled growth upon implantation.

Innovation Solution

The use of soft-gels with optimized viscoelastic properties, specifically fibrin matrices coated with adhesion proteins like collagen and fibronectin, to modulate the growth and quiescence of mesenchymal stem cells, maintaining their telomerase length and preventing uncontrolled proliferation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If adult mesenchymal stem cells are expanded ex vivo for clinical applications, then the cell population increases, but the cells undergo rapid aging which limits further expansion

Engineering Contradiction:
Improvecell populationVSAvoidcell aging
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent changes the mechanical parameter (substrate stiffness) to match the in vivo bone marrow environment (approximately 0.1-1 kPa). This parameter change maintains telomerase length and prevents cellular senescence, allowing continuous expansion without the rapid aging that occurs on conventional stiff substrates.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces a soft gelatinous matrix as an intermediary between the stem cells and the culture environment. This matrix mimics the extracellular matrix of bone marrow and mediates mechanical signals to the cells, preventing aging while allowing expansion.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Duration of action of moving object

If mesenchymal stem cells are immortalized by telomerase transduction to enable unlimited self-renewal, then expansion capability increases, but uncontrolled growth and transformation occur upon implantation

Engineering Contradiction:
Improveself-renewal capacityVSAvoiduncontrolled growth
Core Design Contradiction:
Duration of action of moving objectVSObject-generated harmful factors

Solution Approach 1:

The patent applies preliminary anti-action by using soft substrate stiffness (0.1-1 kPa) to preemptively suppress uncontrolled growth and transformation. This mechanical environment counteracts the potential harmful effects of telomerase transduction before implantation, maintaining safety while enabling unlimited self-renewal.

Inventive Principle:
Principle #9Preliminary anti-action

Solution Approach 2:

The patent creates a dynamic system where the substrate stiffness can be adjusted to match different physiological states. The soft gel matrix provides a dynamic mechanical environment that regulates cell behavior, allowing self-renewal while preventing transformation through mechanical signaling.

Inventive Principle:
Principle #15Dynamics

3Ease of operation

If conventional culture methods are used for mesenchymal stem cells, then ease of operation is maintained, but the cells undergo rapid aging and limited expansion

Engineering Contradiction:
Improveculture simplicityVSAvoidcell expansion
Core Design Contradiction:
Ease of operationVSQuantity of substance

Solution Approach 1:

The patent changes the substrate stiffness parameter to soft gelatinous matrices (0.1-1 kPa) while maintaining conventional culture techniques. This single parameter change prevents rapid aging and enables extensive cell expansion without complicating the culture procedure.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach effectively preserves mesenchymal stem cell populations by regulating their growth and maintaining quiescence, preventing spontaneous differentiation and uncontrolled proliferation, thus enhancing their clinical applicability.

Implementation Method 1

gels having optimized viscoelastic properties

Methodology Applied
Scientific EffectViscoelasticity: Viscoelasticity

Implementation Method 2

said gel matrix having a substantially similar elasticity to the elasticity of the predominant in vivo biological microenvironment

Methodology Applied
Scientific EffectElasticity: Elasticity

Implementation Method 3

coating said soft fibrin matrix with a composition comprising an adhesion protein

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 4

an extracellular material that bind to integrin on the membrane of the somatic stem cell

Methodology Applied
Scientific EffectIntegrin binding: Adhesive

Data Source

PatentUS20190225935A1Low Rigidity Gels for MSC Growth Modulation
Publication Date: 2019.07.25 FUNAKI MAKOTO
  • US20190225935A1 patent drawing
  • US20190225935A1 patent drawing
  • US20190225935A1 patent drawing

AI summary

This invention provides gels and matrices having a rigidity in the range of 0.1-2.5 kPa, methods of manufacturing same, and method of preserving a mesenchymal stem cell population or studying mesenchymal stem cells, comprising same.